From 20th January 2021, the RDS Funding Development Briefings will occur weekly, on a Wednesday at 12 noon.
Each session will cover the latest major funding opportunities, followed by a brief Q&A session. Sessions will also include a spotlight on a particular funding opportunity of strategic importance to BU. The timetable for January & February 2021 is below. Further details will be available on the BU Research Blog a week in advance of the session. Sessions will be recorded and made available after the session for those who cannot attend.
Please email RKEDF@bournemouth.ac.uk to receive the Teams invite for these sessions.
Here is your January & February timetable, with details for March, April & May to follow shortly:
| Date | Spotlight Funding Opportunity |
| Wednesday 20th Jan 12pm | Newton International Fellowships (British Academy & Royal Society) |
| Wednesday 27th Jan 12pm | Phillip Leverhulme Prizes |
| Wednesday 3rd February 12pm | National Institute of Health (US) |
| Wednesday 10th February 12pm | EPSRC Overview including EPSRC Fellowships |
| Wednesday 17th February 12pm | ESRC Overview |
| Wednesday 24th February | Horizon Europe (EU) |
Funding Development Briefings – Here’s what you might have missed…
Funding Development Briefing – Spotlight on: Newton International Fellowships
Funding Development Briefings are back!
Funding development briefings in April and spotlights this year










Nursing Research REF Impact in Nepal
Fourth INRC Symposium: From Clinical Applications to Neuro-Inspired Computation
ESRC Festival of Social Science 2025 – Reflecting back and looking ahead to 2026
3C Event: Research Culture, Community & Cookies – Tuesday 13 January 10-11am
Dr. Chloe Casey on Sky News
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease